Analysis

  • The ten most promising cancer drugs being trialled

    To meet rising demand, companies worldwide are striving to develop cost-effective and innovative therapies for a wide variety of cancer types. Pharmaceutical-technology.com lists some of the most promising oncology drugs...

  • A formula for success: inside Swiss pharma

    Two of the world’s leading pharmaceutical companies, Novartis and Roche, call Switzerland home. So why have these giants, along with many other serious players in the industry, found the Swiss...

  • Can AI reveal complex patterns in biological data?

    Can artificial intelligence be used to extract genomic data and discover relevant biomarkers? Immune-focused AI technology company CytoReason thinks so. Sally Turner finds out more from co-founder and president David...

  • May’s top news stories

    The US Congress passed a ‘right-to-try’ bill that would allow terminally ill patients to seek drugs that are experimental and not fully approved by the US FDA directly from pharmaceutical...

  • Can the gene and cell therapy revolution scale up?

    A manufacturing capacity crunch is causing headaches for the burgeoning cell and gene therapy market. Smaller drug development firms will rely on contract manufacturing organisations to produce the viral vectors...